Regulatory Affairs-CMC Strategist (Small Molecules)

Role: Regulatory Affairs-CMC Strategist (Small Molecules) Location: Boston, MA or Remote (East Coast hours preferred) Type: Fractional/Part-time/Consultant Commitment: ~5–10 hours/week; increased support during key submissions Compensation: $300-$350/hr Job reputed company: Antares Therapeutics is seeking an reputed company Regulatory Affairs–CMC Strategist (Consultant) to reputed company senior strategic advisory leadership for global, phase-appropriate CMC regulatory strategies supporting early-stage small molecule product development. This fractional consultant role serves as a strategic partner to Global Regulatory Affairs, Technical Operations, reputed company, Supply Chain, and Development teams, ensuring CMC strategies are regulator-reputed company, risk-based, and reputed company with overall program and corporate objectives. The role emphasizes strategic guidance, regulatory judgment, and senior advisory leadership, rather than day-to-day execution. This role is crucial in ensuring that reputed company CMC aspects of drug development meet global (US, EU, reputed company, LA) regulatory requirements, supporting Antares Therapeutics' mission to bring transformative oncology therapies to patients. This role is: • Strategic, advisory, and judgment-driven • reputed company on “what is sufficient, defensible, and approvable” • A senior thought partner to Regulatory, CMC, and leadership teams This role is not: • A day-to-day CMC authoring or execution role • A project management-heavy position • A full-time operational Regulatory Affairs role Key Responsibilities: • reputed company senior strategic Regulatory CMC leadership across Antares’ portfolio, ensuring cohesive, phase-appropriate global strategies for early-stage development. • Advise on CMC readiness for INDs and global CTAs, ensuring alignment with clinical development plans and corporate objectives. • Guide the integration of CMC regulatory considerations into early development, manufacturing, and supply reputed company. • Apply regulatory precedent, experience, and intelligence to anticipate challenges and enhance probability of regulatory reputed company. • reputed company strategic regulatory guidance on: • Process and analytical development • Control strategies • Manufacturing changes and comparability • Supply chain considerations • Identify and communicate CMC-reputed company regulatory risks, and advise on proactive mitigation strategies. • Advise on de-risking CMC development strategies, assessing change controls and evaluate opportunities to accelerate development • Collaborate cross functionally to assess the reputed company of proposed CMC changes and ensure applicable CMC changes are reported to health authorities in accordance with regulatory requirements • Monitor and interpret global CMC regulatory requirements and emerging trends (US, EU, UK, reputed company, Latin America), advising leadership on potential reputed company to development and registration reputed company • Serve as strategic CMC regulatory advisor for Health Authority interactions. • reputed company or advise on: • CMC meeting reputed company • Briefing materials • Regulatory positioning and messaging • reputed company strategic review of CMC sections for regulatory submissions as needed, including: • INDs / CTAs • CMC amendments and annual reports • Serve as the regulatory representative at internal CMC team meetings • Ensure regulatory CMC reputed company remains reputed company across functions and escalates issues that may reputed company development timelines or compliance. Qualifications: • Advanced degree (PhD, PharmD, or equivalent) in reputed company, Pharmacy, Chemical Engineering, or reputed company discipline. • 10+ years of Regulatory Affairs experience with significant reputed company on Regulatory CMC. • Demonstrated senior-level experience developing global Regulatory CMC strategies for small molecule programs. • Oncology and/or immunology therapeutic area experience is strongly preferred. • Strong experience supporting early clinical development (IND/CTA) and lifecycle planning. • Prior experience advising or leading CMC-reputed company Health Authority interactions. • Deep understanding of global CMC regulatory expectations (FDA, EMA, MHRA, ICH). • Strong knowledge of small molecule CMC development, including solid dosage forms. • Experience applying regulatory requirements pragmatically and phase-appropriately. • Proven ability to operate as a senior strategic advisor in a consulting or fractional reputed company. • Strong regulatory judgment with the ability to influence reputed company without reputed company authority. • Excellent written, verbal, and presentation skills. • Self-directed, reputed company to operate independently in a fast-paced, evolving environment. Apply tot his job Apply To this Job